Disclosure Management When Returning to Work After a Leave of Absence Due to Mental Illness.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 08 2020
Historique:
pubmed: 5 5 2020
medline: 3 7 2021
entrez: 5 5 2020
Statut: ppublish

Résumé

People with mental illness must often decide the extent to which they want to disclose their mental illness publicly. Especially in the context of work, this is a complex and individual decision. This Open Forum discusses the importance of well-reasoned disclosure management to increase the chances of successful workplace reintegration after a leave of absence due to a mental illness. The authors posit that despite the risks of stigma and discrimination, disclosing a mental illness to an employer can benefit employees. However, proper support is often essential in establishing how to best manage disclosure or nondisclosure.

Identifiants

pubmed: 32362227
doi: 10.1176/appi.ps.201900617
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

855-857

Commentaires et corrections

Type : CommentIn

Auteurs

Anne Lang (A)

kbo-Isar-Amper-Klinikum München Ost, Haar, Germany (Lang, Brieger); Department of Public Mental Health, Clinic for Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany (Rüsch); Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Technical University of Munich, Munich (Hamann).

Nicolas Rüsch (N)

kbo-Isar-Amper-Klinikum München Ost, Haar, Germany (Lang, Brieger); Department of Public Mental Health, Clinic for Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany (Rüsch); Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Technical University of Munich, Munich (Hamann).

Peter Brieger (P)

kbo-Isar-Amper-Klinikum München Ost, Haar, Germany (Lang, Brieger); Department of Public Mental Health, Clinic for Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany (Rüsch); Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Technical University of Munich, Munich (Hamann).

Johannes Hamann (J)

kbo-Isar-Amper-Klinikum München Ost, Haar, Germany (Lang, Brieger); Department of Public Mental Health, Clinic for Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany (Rüsch); Department of Psychiatry and Psychotherapy, Klinikum Rechts der Isar, Technical University of Munich, Munich (Hamann).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH